GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NKX2-4 | hg19_v2_chr20_-_21378666_21378666 | -0.11 | 1.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_49066811 Show fit | 10.35 |
ENST00000442157.1
ENST00000326739.4 |
IMP (inosine 5'-monophosphate) dehydrogenase 2 |
|
chr10_-_28571015 Show fit | 7.60 |
ENST00000375719.3
ENST00000375732.1 |
membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7) |
|
chr2_-_225434538 Show fit | 7.02 |
ENST00000409096.1
|
cullin 3 |
|
chr1_-_153643442 Show fit | 6.46 |
ENST00000368681.1
ENST00000361891.4 |
interleukin enhancer binding factor 2 |
|
chr7_-_96339132 Show fit | 6.39 |
ENST00000413065.1
|
split hand/foot malformation (ectrodactyly) type 1 |
|
chr7_-_93519471 Show fit | 6.34 |
ENST00000451238.1
|
tissue factor pathway inhibitor 2 |
|
chr7_+_116139424 Show fit | 6.18 |
ENST00000222693.4
|
caveolin 2 |
|
chr11_+_62439126 Show fit | 6.07 |
ENST00000377953.3
|
chromosome 11 open reading frame 83 |
|
chr7_+_75932863 Show fit | 6.04 |
ENST00000429938.1
|
heat shock 27kDa protein 1 |
|
chr17_-_38574169 Show fit | 5.91 |
ENST00000423485.1
|
topoisomerase (DNA) II alpha 170kDa |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 11.0 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
1.7 | 10.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 8.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.1 | 7.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.8 | 7.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 6.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) purine-containing compound salvage(GO:0043101) |
0.1 | 6.7 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.3 | 6.3 | GO:0003334 | keratinocyte development(GO:0003334) |
1.0 | 6.2 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 6.2 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 12.3 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.1 | 12.1 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 10.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 9.3 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 8.6 | GO:0009986 | cell surface(GO:0009986) |
1.3 | 8.1 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.6 | 7.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 7.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 7.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.8 | 7.0 | GO:0005827 | polar microtubule(GO:0005827) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 15.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 11.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 11.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
2.6 | 10.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 8.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
1.3 | 8.1 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
1.8 | 7.0 | GO:0031208 | POZ domain binding(GO:0031208) |
0.2 | 6.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 6.7 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 6.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 11.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 9.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 8.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 8.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 7.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 7.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 7.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 6.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 5.5 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 5.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 10.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 10.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 9.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 8.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 7.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 7.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 6.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 5.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 5.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 5.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |